119 related articles for article (PubMed ID: 3976396)
1. Efficacy of Metronidazole in experimental Bacteroides fragilis otitis media.
Thore M; Sjöberg W; Burman LG; Holm SE
Acta Otolaryngol; 1985; 99(1-2):60-6. PubMed ID: 3976396
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole treatment of Bacteroides fragilis infections.
Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
[TBL] [Abstract][Full Text] [Related]
4. [Metronidazole in the treatment of anaerobic infection].
Katranushkova N
Khirurgiia (Sofiia); 1983; 36(1):30-5. PubMed ID: 6137590
[No Abstract] [Full Text] [Related]
5. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
Shimada K; Inamatsu T; Sato K
Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
[TBL] [Abstract][Full Text] [Related]
6. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
7. Bacteroides fragilis-induced intra-abdominal abscess in an experimental model treated with telithromycin (HMR 3647).
Thadepalli H; Chuah SK; Qazi S; Thadepalli F; Gollapudi SV
Chemotherapy; 2001; 47(1):43-9. PubMed ID: 11125232
[TBL] [Abstract][Full Text] [Related]
8. Bacteroides fragilis resistant to metronidazole after long-term therapy.
Ingham HR; Eaton S; Venables CW; Adams PC
Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
[No Abstract] [Full Text] [Related]
9. Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint.
Hickey MM; Davies UM; Dave J; Vogler M; Wall RA
J Infect; 1990 Mar; 20(2):129-33. PubMed ID: 2319145
[TBL] [Abstract][Full Text] [Related]
10. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
Reznikov M; McDonald PJ
Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
Dijkmans BA; Mattie H; Hermans J; van Furth R
J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
[TBL] [Abstract][Full Text] [Related]
13. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis.
Bartlett JG; Dezfulian M; Joiner K
Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635
[TBL] [Abstract][Full Text] [Related]
14. Experimental otitis media in guinea pigs. Serum antibody response to Bacteroides fragilis, Propionibacterium acnes and Peptostreptococcus anaerobius upon challenge.
Thore M
Acta Otolaryngol Suppl; 1984; 414():143-6. PubMed ID: 6598260
[TBL] [Abstract][Full Text] [Related]
15. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
Elsaghier AA; Brazier JS; James EA
J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
[No Abstract] [Full Text] [Related]
16. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Thadepalli H; Chuah SK; Gollapudi S
Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
[TBL] [Abstract][Full Text] [Related]
17. Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and diabetic foot infections.
Wang S; Cunha BA; Hamid NS; Amato BM; Feuerman M; Malone B
J Chemother; 2007 Aug; 19(4):410-6. PubMed ID: 17855185
[TBL] [Abstract][Full Text] [Related]
18. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Brook I; Ledney GD
J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
[TBL] [Abstract][Full Text] [Related]
19. Suppurative labyrinthitis caused by anaerobic bacteria.
Egelund E; Bak-Pedersen K
J Laryngol Otol; 1994 May; 108(5):413-4. PubMed ID: 8035121
[TBL] [Abstract][Full Text] [Related]
20. Bacteroides fragilis meningitis in a premature infant successfully treated with metronidazole.
Webber SA; Tuohy P
Pediatr Infect Dis J; 1988 Dec; 7(12):886-7. PubMed ID: 3211633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
